(Q36788011)

16 August 2017

1 reference

title

Evidence-based approach to the management of sporadic medullary thyroid carcinoma (English)

1 reference

16 August 2017

Jeffrey F Moley

1

1 reference

16 August 2017

Elizabeth A Fialkowski

series ordinal

2

1 reference

16 August 2017

publication date

1 May 2007

1 reference

16 August 2017

published in

World Journal of Surgery

1 reference

16 August 2017

volume

31

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

946-956

1 reference

https://scigraph.springernature.com/pub.10.1007/s00268-006-0846-2

16 August 2017

exact match

0 references

cites work

Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00268-006-0846-2

Management of occult medullary thyroid carcinoma: evidenced only by serum calcitonin level elevations after apparently adequate neck operations

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00268-006-0846-2

Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC)

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00268-006-0846-2

Microsurgical neck dissection for metastasizing medullary thyroid carcinoma

21 January 2018

1 reference

12 December 2020

Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma

1 reference

12 December 2020

ZD6474--a novel inhibitor of VEGFR and EGFR tyrosine kinase activity

1 reference

12 December 2020

Surgical strategy for the treatment of medullary thyroid carcinoma

1 reference

12 December 2020

Disappearance rate of serum calcitonin after total thyroidectomy for medullary thyroid carcinoma

1 reference

12 December 2020

Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinoma

1 reference

12 December 2020

Localization and resection of clinically inapparent medullary carcinoma of the thyroid.

1 reference

12 December 2020

A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.

1 reference

12 December 2020

Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma

1 reference

12 December 2020

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

12 December 2020

The extent of surgery for thyroid medullary cancer

1 reference

12 December 2020

Radioactive iodine treatment in medullary thyroid carcinoma

1 reference

12 December 2020

Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond

1 reference

12 December 2020

Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).

1 reference

12 December 2020

Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma

1 reference

12 December 2020

Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma

1 reference

12 December 2020

Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer

1 reference

12 December 2020

Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter

1 reference

12 December 2020

Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer

1 reference

12 December 2020

Optimal surgery for papillary thyroid carcinoma

1 reference

12 December 2020

Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels

1 reference

12 December 2020

Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients

1 reference

12 December 2020

Single center experience in primary surgery for medullary thyroid carcinoma

1 reference

12 December 2020

Chemoembolization for liver metastases from medullary thyroid carcinoma

1 reference

12 December 2020

Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units

1 reference

12 December 2020

A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancer.

1 reference

12 December 2020

Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients

1 reference

12 December 2020

Radioactive iodine in the treatment of medullary carcinoma of the thyroid

1 reference

12 December 2020

Evidence-based treatment of acute pancreatitis: a look at established paradigms

1 reference

12 December 2020

Occult micro medullary thyroid carcinoma: therapeutic strategy and follow-up

1 reference

12 December 2020

Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level

1 reference

12 December 2020

Rules of evidence and clinical recommendations on the use of antithrombotic agents

1 reference

12 December 2020

Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection

1 reference

12 December 2020

Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation stu

1 reference

12 December 2020

Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.

1 reference

12 December 2020

5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

1 reference

12 December 2020

Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes

1 reference

12 December 2020

Medullary thyroid carcinoma: management of lymph node metastases

1 reference

12 December 2020

Surgical treatment of medullary thyroid carcinoma

1 reference

12 December 2020

Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement

1 reference

12 December 2020

Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection

1 reference

12 December 2020

Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules

1 reference

12 December 2020

Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group

1 reference

12 December 2020

Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma

1 reference

12 December 2020

Lymph node dissection and medullary thyroid carcinoma

1 reference

12 December 2020

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine

1 reference

12 December 2020

Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: is parathyroid transplantation indicated?

1 reference

12 December 2020

Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control

1 reference

12 December 2020

Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer

1 reference

12 December 2020

Should patients with medullary thyroid carcinoma undergo extensive lymph node (re)operation to improve long-term survival?

1 reference

12 December 2020

Latent subclinical medullary thyroid carcinoma: diagnosis and treatment

1 reference

12 December 2020

Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer

1 reference

12 December 2020

Cellular effects of imatinib on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated RET mutations

1 reference

12 December 2020

Improved results of cervical reoperation for medullary thyroid carcinoma

1 reference

12 December 2020

Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid gland

1 reference

12 December 2020

The clinical course after definitive operation for medullary thyroid carcinoma

1 reference

12 December 2020

Medullary carcinoma of the thyroid--therapeutic strategy derived from fifteen years of experience

1 reference

12 December 2020

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

1 reference

12 December 2020

Treatment evaluation, follow-up and familial screening of medullary thyroid carcinoma by highly specific calcitonin measurements.

1 reference

12 December 2020

Reoperation for recurrent or persistent medullary thyroid cancer

1 reference

12 December 2020

Lymph node involvement in macroscopic medullary thyroid carcinoma

1 reference

12 December 2020

Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma

1 reference

12 December 2020

Central neck dissection in the management of sporadic medullary thyroid microcarcinoma

1 reference

12 December 2020

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

1 reference

12 December 2020

The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R

1 reference

12 December 2020

Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations

1 reference

12 December 2020

10.1007/S00268-006-0846-2

Identifiers

DOI

1 reference

16 August 2017

1 reference